V

Verastem
D

VSTM

10.375
USD
-0.23
(-2.12%)
مغلق
حجم التداول
25,035
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
781,442,925
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.